Chronic Chagastic cardiomyopathy associated with membranoproliferative glomerulonephritis: Report of an autopsy case

Masayuki Shintaku1, Shinsaku Takeda2, Sachio Miura3

  • 1Department of Pathology, Shiga General Hospital, Shiga, Japan.

Pathology International
|December 17, 2019
PubMed

Insights

This autopsy report details a case of chronic Chagas disease in a 73-year-old woman, revealing cardiac and kidney damage. The study suggests Trypanosoma cruzi infection may contribute to kidney disease in chronic Chagas patients.

Area of Science:

  • Pathology
  • Infectious Diseases
  • Cardiology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a significant global health concern.
  • Chronic infection can lead to debilitating cardiac complications, known as Chagasic cardiomyopathy.
  • The potential link between Trypanosoma cruzi infection and kidney disease remains an area of investigation.

Observation:

  • An autopsy was performed on a 73-year-old Brazilian woman of Japanese descent with a history of chronic Chagas disease.
  • The patient presented with cardiac insufficiency and autopsy revealed features consistent with chronic Chagasic cardiomyopathy, including myocarditis, fibrosis, and apical aneurysm.
  • Kidney examination showed membranoproliferative glomerulonephritis (MPGN).

Findings:

  • Despite symptoms of chronic Chagas disease, Trypanosoma cruzi protozoa were not detected in the cardiac tissue.
  • The autopsy findings in the heart were characteristic of chronic Chagasic cardiomyopathy.
  • The patient's kidney pathology demonstrated membranoproliferative glomerulonephritis (MPGN).

Implications:

  • This case supports the hypothesis that chronic Trypanosoma cruzi infection can trigger immune complex-mediated glomerulonephritis.
  • The findings suggest a potential role for persistent Trypanosoma cruzi infection in the pathogenesis of MPGN.
  • Further research is warranted to elucidate the mechanisms linking Chagas disease to renal pathology.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
321
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
440
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
401
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
491
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
400
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
439